Crossmark

Formulation and Characterization of pH-Sensitive Ezetimibe Nanomatrix for Enhanced Biopharmaceutical Performance

Crossref DOI link: https://doi.org/10.1007/s12247-026-10444-x

Published Online: 2026-03-10

Published Print: 2026-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Narkhede, Minal https://orcid.org/0000-0002-8068-0450
Daware, Omkar https://orcid.org/0009-0006-7719-3471
Belkare, Chetana https://orcid.org/0009-0006-5822-8587
License Information

Text and Data Mining valid from 2026-03-10

Version of Record valid from 2026-03-10
More Information

Article History

Received: 7 November 2025

Accepted: 7 February 2026

First Online: 10 March 2026

Declarations

:

: The authors declare no competing interests.